These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? a large cross-sectional study. Stomp W, Krabben A, van der Heijde D, Huizinga TW, Bloem JL, van der Helm-van Mil AH, Reijnierse M. J Rheumatol; 2014 Aug; 41(8):1630-7. PubMed ID: 25028382 [Abstract] [Full Text] [Related]
3. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI. Gandjbakhch F, Foltz V, Mallet A, Bourgeois P, Fautrel B. Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693 [Abstract] [Full Text] [Related]
9. Repair of erosions in patients with rheumatoid arthritis treated with etanercept: magnetic resonance imaging findings after 1 year of follow-up. Lisbona M, Maymó J, Solano A, Almirall M, Navallas M, Ares J, Carbonell J. Scand J Rheumatol; 2013 Dec; 42(6):437-44. PubMed ID: 23607571 [Abstract] [Full Text] [Related]
10. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Palosaari K, Vuotila J, Takalo R, Jartti A, Niemelä RK, Karjalainen A, Haapea M, Soini I, Tervonen O, Hakala M. Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155 [Abstract] [Full Text] [Related]
11. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK. Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915 [Abstract] [Full Text] [Related]
12. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543 [Abstract] [Full Text] [Related]
13. Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls. Olech E, Crues JV, Yocum DE, Merrill JT. J Rheumatol; 2010 Feb; 37(2):265-74. PubMed ID: 19955056 [Abstract] [Full Text] [Related]
14. Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Ostendorf B, Scherer A, Mödder U, Schneider M. Arthritis Rheum; 2004 Jul; 50(7):2094-102. PubMed ID: 15248206 [Abstract] [Full Text] [Related]
15. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study. Ji L, Li G, Xu Y, Zhou W, Zhang Z. Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781 [Abstract] [Full Text] [Related]
16. Bone marrow edema in the cervical spine of symptomatic rheumatoid arthritis patients. Narváez JA, Narváez J, de Albert M, De Lama E, Serrallonga M, Nolla JM. Semin Arthritis Rheum; 2009 Feb; 38(4):281-8. PubMed ID: 18336873 [Abstract] [Full Text] [Related]
17. Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy. Ranganath VK, Motamedi K, Haavardsholm EA, Maranian P, Elashoff D, McQueen F, Duffy EL, Bathon JM, Curtis JR, Chen W, Moreland L, Louie J, Amjadi S, O'Dell J, Cofield SS, St Clair EW, Bridges SL, Paulus HE. Arthritis Care Res (Hoboken); 2015 Jul; 67(7):929-39. PubMed ID: 25581612 [Abstract] [Full Text] [Related]
18. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P. Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [Abstract] [Full Text] [Related]